ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Galapagos

Galapagos (GXE)

25.94
0.54
(2.13%)
Closed December 25 3:00PM
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
25.94
Bid
25.86
Ask
26.00
Volume
8,382
25.38 Day's Range 25.78
21.80 52 Week Range 38.90
Market Cap
Previous Close
25.40
Open
25.40
Last Trade
9
@
25.78
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
7,648
Shares Outstanding
65,835,511
Dividend Yield
-
PE Ratio
8.06
Earnings Per Share (EPS)
3.22
Revenue
843.8M
Net Profit
211.7M

About Galapagos

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
Headquarters
Mechelen, Antwerp, Bel
Founded
-
Galapagos is listed in the Coml Physical, Biologcl Resh sector of the Tradegate (DE) with ticker GXE. The last closing price for Galapagos was 25.40 €. Over the last year, Galapagos shares have traded in a share price range of 21.80 € to 38.90 €.

Galapagos currently has 65,835,511 shares outstanding. The market capitalization of Galapagos is 1.67 € billion. Galapagos has a price to earnings ratio (PE ratio) of 8.06.

GXE Latest News

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma Data from the ongoing Phase...

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024 New Phase 1/2 data support the potential of our CAR T-cell therapy candidates, GLPG5101 and GLPG5201, in...

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update We are advancing our pipeline and accelerating innovation through focused execution of our Forward, Faster...

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth

Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth Mechelen, Belgium; October 7, 2024, 07:00 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced...

Galapagos receives transparency notification from EcoR1 Capital

Galapagos receives transparency notification from EcoR1 Capital Mechelen, Belgium; 30 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a...

Galapagos receives transparency notification from EcoR1 Capital

Galapagos receives transparency notification from EcoR1 Capital Mechelen, Belgium; 16 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a...

Galapagos receives transparency notification from FMR LLC

Galapagos receives transparency notification from FMR LLC Mechelen, Belgium; 3 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency...

Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma

Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma Mechelen, Belgium; August 23, 2024, 07:00...

Galapagos receives transparency notification from FMR LLC

Galapagos receives transparency notification from FMR LLC Mechelen, Belgium; 20 August 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency...

Galapagos reports half-year 2024 financial results and provides second quarter business update

Galapagos reports half-year 2024 financial results and provides second quarter business update Executing on our Forward, Faster strategy with strong progress in a pivotal year, focused on...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.722.8548770816825.2225.9224.921178725.52650457DE
4-0.22-0.84097859327226.1626.8624.92670125.6939471DE
12-0.54-2.0392749244726.4828.7823.68764825.28493242DE
261.747.1900826446324.228.7821.8922524.99663401DE
52-10.289999-28.401874921436.22999938.921.8859726.6520551DE
156-23.235-47.249618708749.17566.421.8432927.48663039DE
260-153.01-85.5043308187178.95189.321.8264928.68205858DE

GXE - Frequently Asked Questions (FAQ)

What is the current Galapagos share price?
The current share price of Galapagos is 25.94 €
How many Galapagos shares are in issue?
Galapagos has 65,835,511 shares in issue
What is the market cap of Galapagos?
The market capitalisation of Galapagos is EUR 1.67B
What is the 1 year trading range for Galapagos share price?
Galapagos has traded in the range of 21.80 € to 38.90 € during the past year
What is the PE ratio of Galapagos?
The price to earnings ratio of Galapagos is 8.06
What is the cash to sales ratio of Galapagos?
The cash to sales ratio of Galapagos is 2.02
What is the reporting currency for Galapagos?
Galapagos reports financial results in EUR
What is the latest annual turnover for Galapagos?
The latest annual turnover of Galapagos is EUR 843.8M
What is the latest annual profit for Galapagos?
The latest annual profit of Galapagos is EUR 211.7M
What is the registered address of Galapagos?
The registered address for Galapagos is GENERAAL DE WITTELAAN L11, MECHELEN, ANTWERP, A3 2800
What is the Galapagos website address?
The website address for Galapagos is www.glpg.com
Which industry sector does Galapagos operate in?
Galapagos operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0RARAPT Therapeutics Inc
1.61 €
(101.25%)
83.81k
KASHIntellabridge Technology Corp
0.047 €
(88.00%)
1.24M
4APApollo Minerals Ltd
0.01 €
(66.67%)
30
AWY0Percheron Therapeutics Ltd
0.007 €
(55.56%)
660k
1W81WISeKey International Holding Ltd
9.70 €
(44.78%)
4.81k
013CJDcom Inc
17.426 €
(0.00%)
0
013AJD.com Inc
34.90 €
(0.00%)
0
0110Thesis Gold Inc
0.391 €
(0.00%)
0
00WAspermont Ltd
0.004 €
(0.00%)
0
000Greenvolt Energias Renovaveis SA
0.00 €
(0.00%)
0
013CJDcom Inc
17.426 €
(0.00%)
0
013AJD.com Inc
34.90 €
(0.00%)
0
0110Thesis Gold Inc
0.391 €
(0.00%)
0
00WAspermont Ltd
0.004 €
(0.00%)
0
000Greenvolt Energias Renovaveis SA
0.00 €
(0.00%)
0

Discussion

View Full Feed
surfkast surfkast 7 minutes ago
OTCM

Profile Data
SIC - Industry Classification
7372 - Prepackaged software
Incorporation Information
NV, US, 2004
Employees
3 as of 12/01/2023
Shell
No

https://www.otcmarkets.com/stock/SPZI/overview

SPZI
cfoofme cfoofme 10 minutes ago
Merry Christmas Dale from America , the land of the free (if you aren’t a crook),lol. Hope you enjoy your jailbird prison lunch.
Seminole Red Seminole Red 10 minutes ago
According to NFL reporter Ian Rapoport, the Pittsburgh Steelers will not have the services of quarterback Justin Fields in today's game versus the Kansas City Chiefs. Fields suffered an abdominal injury two weeks ago and was inactive versus the Baltimore Ravens last week.

If Fields ca
surfkast surfkast 11 minutes ago
Can you tell us what meds you are on as you are delusional.
HMBL
ddls ddls 12 minutes ago
It's way too late for this BIELshit.

BIEL is finished, DONE, is that understood? 😎
BIEL
hnbadger1 hnbadger1 14 minutes ago
The shorts are getting desperate! This is there latest attempt-
Anavex Life Sciences Faces
Manufacturing Challenges Impacting Product Launch and Financial Stability
Anavex Life Sciences (AVXL) has disclosed a new risk, in the
Manufacturing category. Anavex Life Sciences f
AVXL
jammy32 jammy32 14 minutes ago
Just my opinion. When / if elite does buy the adderall back from MIKAH, it will be because the volume is drying up and moving to vyvance. So the question for me is would a neutral Elite CEO even consider the purchase. This whole MIkAH thing really bothers me as it’s obvious that Nasrat / MIKAH
ELTP
iclight iclight 15 minutes ago
That’s like a bank robber voluntarily giving himself up when 20 officers have guns pointed at him when he walks out the front door after a robbery.
NWBO
surfkast surfkast 16 minutes ago
Merry Christmas to those who celebrate.
santafe2 santafe2 16 minutes ago
I think within this context the somewhat pejorative word nitch to describe Tesla is correct. It's just small. Although you're correct, nitch isn't a word you'd likely find in the NYT, we use niche in English to signify small but also exclusive or special. Tesla is neither.
surfkast surfkast 18 minutes ago
I was making fun of the claim George is saving money by not maintaining the websites as some have claimed.
As for his stable of 100 or so horses, industry standards are in the $45,000 range per horse annually. His stable probably is his biggest business expense. (Hobby/addiction)
Keep
SRNW
cottonmather cottonmather 18 minutes ago
Mike Dawe and Tommy Emmanuel play a few. I've played with Tommy twice..... never met Mike. Many claim Mike is the best on the planet. He is a percussionist and rips the guitar apart in solo. His guitar here is an $11K Breedlove. Tommy is badass in a different genre playing a $9k MP. Clean simp
SkeBallLarry SkeBallLarry 20 minutes ago
" on This Day ~ a Merry Christmas ~ GmenFan " .. !!
vein vein 20 minutes ago
What are you implying lighting rod ?
LWLG
DMC8 DMC8 22 minutes ago
Published: 25 December 2024
https://www.imrpress.com/journal/RCM/25/12/10.31083/j.rcm2512459/htm
AMRN
werd werd 22 minutes ago
Tis the season! Enjoy your down time✌️

$$$GTCH$$$

GLTA
GTCH
edbi46 edbi46 24 minutes ago
Lets see how high our beloved BIEL gets TRUMPed/JFK JUNIORed/DR. OZed up by Jan. 1, before NOPAIN Act is activated ( and, specifically, after!!! ) !!!!!

No WORD SALADS, no SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS, ( for like 13 years, from Oct. 2011 and counting?? ), did/will do any d
MCF WBA
$PennyMover $PennyMover 26 minutes ago
https://x.com/otcgrlf/status/1871732083821031827
GRLF
LetGoodTimesRoll LetGoodTimesRoll 26 minutes ago
Seamus Clause 🎅 is coming!!

$RNVA ==>$FOXO $$$$$$$$

Merry Holidaze!!
FOXO RNVA
kbaz kbaz 27 minutes ago
Wishing a Blessed and Merry Christmas to all of the $FRZT Family. Thank you from some of the shareholder family... Hoping to see what you have been Developing and Building in '25. We know it's going to be GRAND!!!!! Here's to wishing it will be BlockChain DEX coming to revolutionize mo
FRZT
jjr04001 jjr04001 31 minutes ago
Healthcare in the U.S. has a chance of improving only when CVS is finally out of the healthcare and pharmacy business. What a beautiful sight to see.
CVS
stockinspector stockinspector 33 minutes ago
Merry Christmas to everyone!
WDLF

Your Recent History

Delayed Upgrade Clock